Search
Menu
Home
HTB
2019
April
30
30 April 2019
Contents
Editorial
HTB 30 April 2019: vol 20 no 5 – BHIVA and CROI reports
Conference reports
25th Annual BHIVA Conference (BHIVA 2019)
BHIVA preconference: U=U and HIV and immigration detention
Conference on Retroviruses and Opportunistic Infections (CROI 2019): third reports
bNAb research at CROI 2019: vaccine, prevention, treatment and cure…
Paediatric dolutegravir update
Other cure related studies at CROI 2019
Antiretrovirals
Dual long-acting cabotegravir/rilpivirine injection submitted to FDA
Dolutegravir/3TC dual FDC (Dovato) approved in the US and given positive opinion in the EU
Other news
King’s launches transgender sexual health service with cliniQ
PDFs
30 April 2019 vol 20 no 5
HTB RSS
Early access
HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines
30 June 2025
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
28 June 2025
Clinical studies of two once-weekly pipeline compounds put on hold
27 June 2025
UK HIV care for transgender and non-binary people: comment on unworkable EHRC guidelines by 30 June
26 June 2025
All early access reports
Current issues
June 2025
May 2025
April 2025
Back issues
Special report
UK HIV care for transgender and non-binary people: comment on unworkable EHRC guidelines by 30 June
26 June 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate